DIN 02497220 — CABENUVA 300 MG; 200 MG
CABENUVA is a kit; suspension (extended-release) of Rilpivirine / Cabotegravir marketed by VIIV HEALTHCARE ULC. The full Rilpivirine / Cabotegravir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02497220
- Brand name
- CABENUVA
- Active ingredient
- Rilpivirine / Cabotegravir
- Strength
- 300 MG; 200 MG
- Dosage form
- KIT; SUSPENSION (EXTENDED-RELEASE)
- Route
- INTRAMUSCULAR
- Manufacturer
- VIIV HEALTHCARE ULC
- Health Canada status
- MARKETED
- Drug class
- Complete antiretroviral regimen combining a non-nucleoside reverse transcriptase inhibitor (rilpivirine) and an integrase strand transfer inhibitor (cabotegravir)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rilpivirine / Cabotegravir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02497247 | CABENUVA | 200 MG; 300 MG | KIT; SUSPENSION (EXTENDED-RELEASE) | VIIV HEALTHCARE ULC | MARKETED |